http://www.zibb.com/all/theme/cq/Allergan+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Thu, 19 Nov 2009 20:39:00 GMTThu, 19 Nov 2009 20:39:00 GMT608831http://www.zibb.com/all/theme/cq/Allergan+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.marketwatch.com/story/senate-bill-weighs-on-allergan-medicis-2009-11-19?siteid=rss&rss=1Allergan Inc. and Medicis Pharmaceutical Corp. shares fall on news that a new bill proposed by Senate Democrats would levy a 5% excise tax on elective cosmetic procedures.http://www.marketwatch.com/story/senate-bill-weighs-on-allergan-medicis-2009-11-19?siteid=rss&rss=1Allergan IncorporatedThu, 19 Nov 2009 20:39:00 GMThttp://www.foxbusiness.com/story/markets/industries/health-care/allergan-medicis-lead-drug-stocks-lower/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+foxbusiness%2Fhealthcare+%28FOXBusiness.com+-+Industries+-+Health+Care%29Allergan, Medicis Lead Drug Stocks Lowerhttp://www.foxbusiness.com/story/markets/industries/health-care/allergan-medicis-lead-drug-stocks-lower/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+foxbusiness%2Fhealthcare+%28FOXBusiness.com+-+Industries+-+Health+Care%29Allergan IncorporatedThu, 19 Nov 2009 15:03:00 GMThttp://www.zibb.com/article/5658453/Allergan+AGN+NewsBite+AGN+Hits+Week+HighAllergan (NYSE: AGN) hit a new 52-Week high of $60.25 so far today. Currently the stock is up $0.10 (0.16%) to $59.97 on 712,947 shares traded. Today's high is up $31.02 from a 52-Week Low of $28.95. Allergan stock has been showing support around $56.76 and resistance in the $61.46 range. Technicalhttp://www.zibb.com/article/5658453/Allergan+AGN+NewsBite+AGN+Hits+Week+HighAllergan IncorporatedTue, 10 Nov 2009 14:02:14 GMThttp://www.packworld.com/webonly-28527precedent-setting. A press release on Allergan s Web site says, Under current law, drugs are approved by the FDA for specific uses. Once a drug is approved, physicians may exercise their informed medical judgment to prescribe the drug for any use, including off-label uses.http://www.packworld.com/webonly-28527Allergan IncorporatedWed, 04 Nov 2009 18:20:35 GMThttp://www.bloggingstocks.com/2009/10/31/earnings-highlights-aetna-allergan-e-trade-goodyear-radiosh/Filed under: Earnings reports, Allergan (AGN), Aetna Inc (AET), <ahttp://www.bloggingstocks.com/2009/10/31/earnings-highlights-aetna-allergan-e-trade-goodyear-radiosh/Allergan IncorporatedSat, 31 Oct 2009 21:10:00 GMThttp://finance.yahoo.com/news/Allergan-Beats-Raises-zacks-1677992571.html?x=0&.v=1Allergan, Inc. (NYSE: AGN - News) reported third quarter earnings of 70 cents per share, a cent above the Zacks Consensus Estimate and 7.7% above thehttp://finance.yahoo.com/news/Allergan-Beats-Raises-zacks-1677992571.html?x=0&.v=1Allergan IncorporatedFri, 30 Oct 2009 13:01:06 GMThttp://seekingalpha.com/article/170002-allergan-q3-2009-earnings-call-transcript?source=yahooHello and welcome to the Allergan Third Quarter 2009 Earnings Call. Following today's presentation, there will be a formal question-and-answer session. (Operator Instructions). Until then, all lines will remain on listen-only mode. As a request of the company, today's conference is being recorded.http://seekingalpha.com/article/170002-allergan-q3-2009-earnings-call-transcript?source=yahooAllergan IncorporatedFri, 30 Oct 2009 00:30:24 GMThttp://online.wsj.com/article/BT-CO-20091029-717117.htmlDow Jones Reprints: This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool at the bottom of any article or visit www.djreprints.com See a sample reprint in PDF format.http://online.wsj.com/article/BT-CO-20091029-717117.htmlAllergan IncorporatedThu, 29 Oct 2009 16:43:47 GMThttp://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/10/29/financial/f083935D97.DTL&feed=rss.businessAllergan Inc. said Thursday its third-quarter profit rose 8 percent on a boost in eye care and Botox wrinkle treatment sales. Allergan earned $179 million, or 58 cents per share, up from profit of $165.4 million, or 54 cents per share, during the same period...http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/10/29/financial/f083935D97.DTL&feed=rss.businessAllergan IncorporatedThu, 29 Oct 2009 15:40:41 GMThttp://news.yahoo.com/s/ap/20091029/ap_on_bi_ge/us_earns_allerganAllergan Inc. said Thursday its third-quarter profit rose 8 percent on a boost in eye care and Botox wrinkle treatment sales.http://news.yahoo.com/s/ap/20091029/ap_on_bi_ge/us_earns_allerganAllergan IncorporatedThu, 29 Oct 2009 15:39:35 GMThttp://www.law.com/jsp/article.jsp?id=1202434977566&rss=newswireIncisive Media's Law.com is the Web's leading legal news and information network for attorneys and other legal professionals.http://www.law.com/jsp/article.jsp?id=1202434977566&rss=newswireAllergan IncorporatedWed, 28 Oct 2009 02:28:23 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9172Allergan, Inc. (NYSE:AGN) announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. (http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9172Allergan IncorporatedMon, 26 Oct 2009 01:00:00 GMThttp://www.pointoflaw.com/archives/2009/10/beck-herrmann-o.phpMichael Krauss recently summarized the interesting suit by drug maker Allergan contesting, on First Amendment grounds, the FDA's ban on truthful off-label marketing of approved pharmaceuticals. Beck and Herrmann at Drug and Device Law have much to say about the...http://www.pointoflaw.com/archives/2009/10/beck-herrmann-o.phpAllergan IncorporatedSun, 11 Oct 2009 03:23:21 GMThttp://www.medpagetoday.com/ProductAlert/Prescriptions/16268The maker of Botox (onabotulinumtoxin A) is asking a federal district court to allow it to share truthful information about off-label uses of the drug without risk of penalty from either the FDA orhttp://www.medpagetoday.com/ProductAlert/Prescriptions/16268Allergan IncorporatedFri, 02 Oct 2009 18:07:58 GMThttp://www.dailyreportonline.com/Editorial/News/singleEdit.asp?individual_SQL=10/2/2009@35688&rssFeed=freeNEW YORK (AP) — Botox wrinkle treatment maker Allergan Inc. filed a lawsuit Thursday challenging the government's ban on off-label drug marketing to doctors, saying it violates the company's right to freedom of speech.http://www.dailyreportonline.com/Editorial/News/singleEdit.asp?individual_SQL=10/2/2009@35688&rssFeed=freeAllergan IncorporatedFri, 02 Oct 2009 17:42:00 GMThttp://www.usatoday.com/money/industries/health/2009-10-02-allergan_N.htm?csp=34Allergan, the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug marketing to doctors, saying it violates the company's free speech rights.http://www.usatoday.com/money/industries/health/2009-10-02-allergan_N.htm?csp=34Allergan IncorporatedFri, 02 Oct 2009 15:54:03 GMThttp://www.dailyfinance.com/2009/10/02/allergan-is-suing-u-s-to-allow-it-to-promote-botox-for-off-labe/In a reversal of the traditional roles, Allergan Inc. (AGN) is suing the U.S. government, claiming current rules on so-called off-label drug promotion violate its First Amendment right to free speech. It wants to be allowed to "share relevant information with the medical community on the safe use"http://www.dailyfinance.com/2009/10/02/allergan-is-suing-u-s-to-allow-it-to-promote-botox-for-off-labe/Allergan IncorporatedFri, 02 Oct 2009 15:36:38 GMThttp://abcnews.go.com/Business/wireStory?id=8733091Allergan Inc., the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug marketing to doctors, saying it violates the company's right to freedom of speech.http://abcnews.go.com/Business/wireStory?id=8733091Allergan IncorporatedFri, 02 Oct 2009 15:27:16 GMThttp://www.rdmag.com/News/FeedsAP/2009/10/life-sciences-allergan-suing-fda-over-off-label-policy/Allergan suing US regulators, saying off-label marketing policy violates free-speech rightshttp://www.rdmag.com/News/FeedsAP/2009/10/life-sciences-allergan-suing-fda-over-off-label-policy/Allergan IncorporatedFri, 02 Oct 2009 15:25:54 GMThttp://losangeles.bizjournals.com/losangeles/stories/2009/09/28/daily37.html?ana=yfcpchas filed a lawsuit against the federal government challenging federal rules preventing drug companies from educating doctors on alternative, or "off-label" uses for drugs. In the lawsuit, Allergan contends the ban violates First-Amendment rights. When a drug is approved by the U.S.http://losangeles.bizjournals.com/losangeles/stories/2009/09/28/daily37.html?ana=yfcpcAllergan IncorporatedFri, 02 Oct 2009 15:05:14 GMThttp://www.biospace.com/news_story.aspx?StoryID=157877&full=1Some of these off-label uses are medically accepted and commonly prescribed but currently unapproved by the United States Food and Drug Administration (FDA).http://www.biospace.com/news_story.aspx?StoryID=157877&full=1Allergan IncorporatedFri, 02 Oct 2009 12:00:00 GMThttp://commonlaw.findlaw.com/2009/09/latisse-side-effects-fda-warns-allergan-over-misleading-claims.htmlThis is not about failure to include something in the fine print of an ad or laundry list at the end of a TV commercial, but instead about the website where consumers go to find out basic information about what risks Latisse might pose. The FDA's problems with the Latisse site include:http://commonlaw.findlaw.com/2009/09/latisse-side-effects-fda-warns-allergan-over-misleading-claims.htmlAllergan IncorporatedFri, 18 Sep 2009 20:07:43 GMThttp://www.drugstorenews.com/story.aspx?id=116091Allergan on Sept. 10 received a warning letter from the Food and Drug Administration around its online promotion of its prescription eyelash thickener/glaucoma treatment Latisse, according to published reports.http://www.drugstorenews.com/story.aspx?id=116091Allergan IncorporatedThu, 17 Sep 2009 15:30:00 GMThttp://www.injuryboard.com/national-news/fda-warns-about-eyelash-enhancer-claims.aspx?googleid=270922The Food and Drug Administration FDA Thursday warned Allergan Inc maker of eyelash thickner Latisse that it is misleading the public because it downplays the risks associated with the product including turning light eyes darkhttp://www.injuryboard.com/national-news/fda-warns-about-eyelash-enhancer-claims.aspx?googleid=270922Allergan IncorporatedThu, 17 Sep 2009 11:49:21 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-15-2009/0005093846&EDATE=Pieris is developing Anticalins for the treatment of a variety of disorders. Anticalins are a novel class of biologic drugs that are engineered to bind disease-relevant targets with high affinity and specificity.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-15-2009/0005093846&EDATE=Allergan IncorporatedTue, 15 Sep 2009 08:00:00 GMT